202 related articles for article (PubMed ID: 33595422)
1. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism.
Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D
Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422
[TBL] [Abstract][Full Text] [Related]
2. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
Shang H; Sun Y; Wang Z; Zhou Y; Yang H; Ci X; Cui T; Xia Y; Gu Y; Liao M; Li Q; Si D; Liu C
J Ethnopharmacol; 2022 May; 289():115006. PubMed ID: 35051604
[TBL] [Abstract][Full Text] [Related]
4. Influence of verapamil on the pharmacokinetics of oridonin in rats.
Liu J; Zhang N; Li N; Fan X; Li Y
Pharm Biol; 2019 Dec; 57(1):787-791. PubMed ID: 31747844
[No Abstract] [Full Text] [Related]
5. Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.
Choi DH; Chung JH; Choi JS
Eur J Clin Pharmacol; 2010 Mar; 66(3):285-90. PubMed ID: 20012601
[TBL] [Abstract][Full Text] [Related]
6. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
[No Abstract] [Full Text] [Related]
7. Effects of verapamil on the pharmacokinetics of puerarin in rats.
Zhou Y; Song X; Dong G
Xenobiotica; 2019 Oct; 49(10):1178-1182. PubMed ID: 30173622
[TBL] [Abstract][Full Text] [Related]
8. The effects of verapamil on the pharmacokinetics of curculigoside in rats.
Wang K; Zhao J; Lang J
Pharm Biol; 2016 Dec; 54(12):3001-3008. PubMed ID: 27328778
[TBL] [Abstract][Full Text] [Related]
9. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
Choi JS; Choi I; Choi DH
Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740
[TBL] [Abstract][Full Text] [Related]
10. Influence of verapamil on pharmacokinetics of pristimerin in rats.
Gao X; Zhang Y; Wang Y; Zhang Y; Wang Y; Liu S; Gao X
Biomed Chromatogr; 2016 Jun; 30(6):802-9. PubMed ID: 26347996
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between peimine and paeoniflorin in rats and its potential mechanism.
Chen Q; Yin C; Li Y; Yang Z; Tian Z
Pharm Biol; 2021 Dec; 59(1):129-133. PubMed ID: 33721550
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
Suzuki K; Taniyama K; Aoyama T; Watanabe Y
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
[TBL] [Abstract][Full Text] [Related]
15. Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism.
Wang H; Dong L; Qu F; He H; Sun W; Man Y; Jiang H
Pharm Biol; 2020 Dec; 58(1):352-356. PubMed ID: 32298152
[No Abstract] [Full Text] [Related]
16. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
Mudavath S; Ashok D
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats.
Zhang J; Xie Q; Kong W; Wang Z; Wang S; Zhao K; Chen Y; Liu X; Liu L
J Pharm Pharmacol; 2020 Mar; 72(3):448-460. PubMed ID: 31863502
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats.
Choi DH; Li C; Choi JS
Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):163-8. PubMed ID: 20166433
[TBL] [Abstract][Full Text] [Related]
19. Nonlinear pharmacokinetics of oral quinidine and verapamil in healthy subjects: a clinical microdosing study.
Maeda K; Takano J; Ikeda Y; Fujita T; Oyama Y; Nozawa K; Kumagai Y; Sugiyama Y
Clin Pharmacol Ther; 2011 Aug; 90(2):263-70. PubMed ID: 21716273
[TBL] [Abstract][Full Text] [Related]
20. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
